Hwang et al.1 recently published a retrospective analysis of the risk of hospitalization or mortality in patients with Parkinson disease (PD) using pimavanserin in long-term care facilities. However, the study… Click to show full abstract
Hwang et al.1 recently published a retrospective analysis of the risk of hospitalization or mortality in patients with Parkinson disease (PD) using pimavanserin in long-term care facilities. However, the study design and cohort selection do not support the authors' conclusions.
               
Click one of the above tabs to view related content.